|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/51 | |
| A61K 39/00 | |||
| A61K 39/39 | |||
| A61P 37/04 | |||
| A61P 35/00 | |||
| A61P 31/00 |
| (11) | Number of the document | 1954252 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06851781.2 |
| Date of filing the European patent application | 2006-12-01 | |
| (97) | Date of publication of the European application | 2008-08-13 |
| (45) | Date of publication and mention of the grant of the patent | 2016-02-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/046212 |
| Date | 2006-12-01 |
| (87) | Number | WO 2008/051245 |
| Date | 2008-05-02 |
| (30) | Number | Date | Country code |
| 741860 P | 2005-12-02 | US | |
| 775265 P | 2006-02-21 | US |
| (72) |
WENDORF, Janet R., US
SINGH, Manmohan, US
O`HAGAN, Derek T., US
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | NANOPARTICLES FOR USE IN IMMUNOGENIC COMPOSITIONS |
| NANOPARTICLES FOR USE IN IMMUNOGENIC COMPOSITIONS |